Best Practices

The Multiple Sclerosis Centers of Excellence: A Model of Excellence in the VA

Author and Disclosure Information

 

References

MSCoE Resources

The MSCoE is funded by VA Central Office through the Office of Specialty Care by Special Purpose funds. The directive specifies that funding for the regional and support programs is through Veterans Equitable Resource Allocation based on VISN and facility workload and complexity. Any research is funded separately through grants, some from VA R&D and others from other sources including the National Institutes of Health, the Patient Centered Outcome Research Institute, affiliated universities, the NMSS, the MS Society of Canada, the Consortium of MS Centers, foundations, and industry.

In 2019, MSCoE investigators received grants totaling > $18 million in funding. In-kind support also is provided by the PVA, the CMSC, the NMSS, and others. The first 3 foundations have been supporters since the inception of the MSCoE and have provided opportunities for the dissemination of education and research for HCPs, fellows, residents and medical students; travel; meeting rooms for MSCoE national meetings; exhibit space for HCP outreach; competitive research and educational grant support; programming and resources for veterans and significant others; organizational expertise; and opportunities for VA HCPs, veterans, and caregivers to learn how to navigate MS with others in the private sector.

Conclusion

The MSCoE had a tremendous impact on improving the consistency and quality of care for veterans with MS through clinical care, research, education and informatics and telehealth. Since opening in 2003, there has been an increase in the number of MS specialty clinics, served veterans with MS, and veterans receiving specialty neurologic and rehabilitation services in VA. Research programs in MS have been initiated to address key questions relevant to veterans with MS, including immunology, epidemiology, clinical care, and rehabilitation. Educational programs and products have evolved with technology and had a greater impact through partnerships with veteran and MS nonprofit organizations.

MSCoE strives to minimize impairment and maximize quality of life for veterans with MS by leveraging integrated electronic health records, data repositories, and telehealth services. These efforts have all improved veteran health, access and safety. We look forward to continuing into the next decade by bringing fresh ideas to the care of veterans with MS, their families and caregivers.

Pages

Recommended Reading

Certain DMTs in MS may attenuate COVID-19 vaccines
Federal Practitioner
Postoperative Neurologic Deficits in a Veteran With Recent COVID-19
Federal Practitioner
Missed visits during pandemic cause ‘detrimental ripple effects’
Federal Practitioner
Disease progression and therapy response vary in MS by ethnicity
Federal Practitioner
Palliative care for patients with dementia: When to refer?
Federal Practitioner
Sun exposure linked to reduced pediatric MS risk
Federal Practitioner
Novel Alzheimer’s drug slows cognitive decline in phase 2 trial
Federal Practitioner
Neurologic drug prices jump 50% in five years
Federal Practitioner
Can supplementary estrogen relieve MS symptoms in menopausal women?
Federal Practitioner
Cannabinoids promising for improving appetite, behavior in dementia
Federal Practitioner

Related Articles